Delivery Order SPE2DB20D2104-SPE2DB22FQ95B
- Not listed
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA). The $1,385.37 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,357.92 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 22, 2023 and was awarded on August 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- The federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mls, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,046.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mLs pharmaceutical products to the Defense Logistics Agency (DLA). The $3,523.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of November 15, 2023 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA). The award, valued at $9,578.88, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of September 28, 2021 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA). The contract, valued at $7,580.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $3,928.62 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of March 8, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $5,541.48, is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA is valued at up to $999,999,999.00 and runs through November 2026, providing a comprehensive range of...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $10,136.69, was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FQ95BDelivery Order
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,281.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 8, 2021. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 11/8/21 |